$63.62
0.73% yesterday
Nasdaq, Jul 03, 10:33 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Stock price

$63.62
-1.93 2.94% 1M
+23.24 57.55% 6M
+21.71 51.80% YTD
+28.16 79.41% 1Y
+21.68 51.69% 3Y
+21.68 51.69% 5Y
+21.68 51.69% 10Y
Nasdaq, Closing price Wed, Jul 03 2024
+0.46 0.73%
ISIN
US74276L1052
Symbol
PRCT
Sector

Key metrics

Market capitalization $3.27b
Enterprise Value $3.13b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 20.01
P/S ratio (TTM) P/S ratio 20.93
P/B ratio (TTM) P/B ratio 12.38
Revenue growth (TTM) Revenue growth 83.44%
Revenue (TTM) Revenue $156.33m
EBIT (operating result TTM) EBIT $-108.44m
Free Cash Flow (TTM) Free Cash Flow $-126.17m
Cash position $225.58m
EPS (TTM) EPS $-2.12
P/E forward negative
P/S forward 15.31
EV/Sales forward 14.63
Short interest 12.01%
Show more

Is PROCEPT BioRobotics a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.

PROCEPT BioRobotics Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a PROCEPT BioRobotics forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a PROCEPT BioRobotics forecast:

Buy
89%
Hold
11%

Financial data from PROCEPT BioRobotics

Dec '23
+/-
%
Net Profit -106 -106
22% 22%
-78%
Depreciation and Amortization 3.81 3.81
12% 12%
3%
Stock Compensation 19 19
85% 85%
14%
Operating Cash Flow -108 -108
34% 34%
-79%
Investments 25 25
851% 851%
19%
Dividend Paid - -
-
-
Free Cash Flow -133 -133
60% 60%
-98%

In millions USD.

Don't miss a Thing! We will send you all news about PROCEPT BioRobotics directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PROCEPT BioRobotics Stock News

Positive
InvestorPlace
7 days ago
Right now, growth investors are focused primarily on opportunities in the semiconductors and artificial intelligence stocks space. That's understandable, given how fast technology is advancing in those areas right now.
Neutral
GlobeNewsWire
17 days ago
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that the American Medical Association (“AMA”) has established a new Current Procedural Terminology (“CPT”) Category I code for transurethral waterjet r...
Neutral
GlobeNewsWire
about one month ago
SAN JOSE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Truist Securities MedTech Conference in Boston, Massachusetts. Management is scheduled to present on T...
More PROCEPT BioRobotics News

Company Profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Reza Zadno
Employees 626
Founded 2007
Website www.procept-biorobotics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today